Drawing for ACROSIS

USPTO serial 79342204

ACROSIS

Reviewed by CopyMark Law Group

Reg. 7483759Status 700Registered
Filing date
Status date
Registration date
Aug 27, 2024
Examiner
COLLOPY, DIANE PATRICIA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ACROSIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Leigh Ann Lindquist

Leigh Ann Lindquist SUGHRUE MION, PLLC2000 Pennsylvania Avenue NW, Suite 9000Washington, DC 20006UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Reagent paper for inspection, other than for medical or veterinary purposes; diagnostic reagents for scientific or research use; in vitro diagnostic reagents for scientific purposes; diagnostic preparations for scientific or research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; chemical test paper, other than for medical or veterinary purposes; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; reagents for analyzing nucleic acid for scientific or laboratory purposes; reagents for extracting nucleic acid for scientific or laboratory purposes; reagents for use in scientific apparatus for chemical or biological analysisACTIVE—
009Laboratory instruments, other than for medical use, namely for analyzing biological sample; laboratory apparatus for the collection and preservation of biological, chemical or diagnostic samples; laboratory incubators, other than for medical use; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluidsACTIVE—
010Genetic testing apparatus for medical purposes; medical device in the nature of pads for medical use in applying a fluid to the skin; medical devices for collecting and preserving biological and chemical samples for medical genetic testing purposes; medical diagnostic apparatus and instruments for testing or analyzing blood, serum, saliva, virus, urine or body fluidsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 1, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 12, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 12, 2025FIMPFINAL DISPOSITION PROCESSED—
Nov 27, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 27, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 27, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 11, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 11, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 22, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 6, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 6, 2024XAECEXAMINER'S AMENDMENT ENTERED—
May 6, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 6, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
May 6, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 12, 2024DOCKASSIGNED TO EXAMINER—
Dec 3, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Nov 15, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 15, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 23, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 23, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 23, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 21, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 21, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 21, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 13, 2023RFNTREFUSAL PROCESSED BY IB—
Mar 22, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 22, 2023RFRRREFUSAL PROCESSED BY MPU—
Jan 27, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 26, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 19, 2023DOCKASSIGNED TO EXAMINER—
Jun 14, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 10, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 9, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance